Palisade Bio, Inc.
DE ˙ DB
SecurityDE:7NS0 / Palisade Bio, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership1,546,240 shares
Latest Disclosed Value $ 2,707,443
Geode Capital Management, Llc reports 1.23% decrease in ownership of 7NS0 / Palisade Bio, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 1,546,240 shares of Palisade Bio, Inc. (DE:7NS0) valued at $2,707,443 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 1,565,452 shares of Palisade Bio, Inc.. This represents a change in shares of -1.23% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PALISADE BIO COM 696389402 1,546,240 -19,212 -1.23 2,707 -26.44 0.0001
2026-02-09 2025-12-31 13F PALISADE BIO COM 696389402 1,565,452 1,538,832 5,780.74 3,681 16,627.27 0.0002
2025-11-12 2025-09-30 13F PALISADE BIO COM 696389402 26,620 1,888 7.63 23 37.50 0.0000
2025-08-08 2025-06-30 13F PALISADE BIO COM 696389402 24,732 0 0.00 17 0.00 0.0000
2025-05-13 2025-03-31 13F PALISADE BIO COM 696389402 24,732 14,680 146.04 17 0.00 0.0000
2025-02-12 2024-12-31 13F PALISADE BIO COM 696389402 10,052 10,052 17 0.0000
2023-02-13 2022-12-31 13F PALISADE BIO COM 696389105 0 -130,017 -100.00 0 -100.00
2022-11-14 2022-09-30 13F PALISADE BIO COM 696389105 130,017 0 0.00 12 -77.36 0.0000
2022-08-12 2022-06-30 13F PALISADE BIO COM 696389105 130,017 3,081 2.43 53 -60.45 0.0000
2022-05-13 2022-03-31 13F PALISADE BIO COM 696389105 126,936 -81,627 -39.14 134 -50.55 0.0000
2022-02-11 2021-12-31 13F PALISADE BIO COM 696389105 208,563 37,033 21.59 271 -40.31 0.0000
2021-11-12 2021-09-30 13F PALISADE BIO COM 696389105 171,530 146,855 595.16 454 354.00 0.0001
2021-08-13 2021-06-30 13F PALISADE BIO COM 696389105 24,675 -94,586 -79.31 100 -50.50 0.0000
2021-05-12 2021-03-31 13F SENECA BIOPHARMA COM 81689B103 119,261 -907,144 -88.38 202 -28.62 0.0000
2017-02-14 2016-12-31 13F NEURALSTEM COM 64127R302 1,026,405 1,196 0.12 283 -13.72 0.0001
2016-11-10 2016-09-30 13F NEURALSTEM COM 64127R302 1,025,209 531,692 107.74 328 129.37 0.0002
2016-08-12 2016-06-30 13F NEURALSTEM COM 64127R302 493,517 0 0.00 143 -61.35 0.0001
2016-05-13 2016-03-31 13F NEURALSTEM COM 64127R302 493,517 -299 -0.06 370 -27.17 0.0002
2016-02-12 2015-12-31 13F NEURALSTEM COM 64127R302 493,816 29,000 6.24 508 -10.41 0.0003
2015-11-13 2015-09-30 13F NEURALSTEM COM 64127R302 464,816 9,598 2.11 567 -35.79 0.0003
2015-08-14 2015-06-30 13F NEURALSTEM COM 64127R302 455,218 -54,544 -10.70 883 -8.78 0.0005
2015-05-14 2015-03-31 13F NEURALSTEM COM 64127R302 509,762 3,348 0.66 968 -29.70 0.0006
2015-02-12 2014-12-31 13F NEURALSTEM COM 64127R302 506,414 0 0.00 1,377 -17.10 0.0008
2014-11-14 2014-09-30 13F NEURALSTEM COM 64127R302 506,414 72,373 16.67 1,661 -9.28 0.0011
2014-08-13 2014-06-30 13F NEURALSTEM COM 64127R302 434,041 48,896 12.70 1,831 13.52 0.0012
2014-05-14 2014-03-31 13F NEURALSTEM COM 64127R302 385,145 122,013 46.37 1,613 110.85 0.0011
2014-02-14 2013-12-31 13F NEURALSTEM COM 64127R302 263,132 42,498 19.26 765 27.93 0.0005
2013-11-14 2013-09-30 13F NEURALSTEM COM 64127R302 220,634 0 0.00 598 81.76 0.0005
2013-08-14 2013-06-30 13F NEURALSTEM COM 64127R302 220,634 220,634 329 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.